SLC16A4 and prostate carcinoma: In Pereira’s study, to maintain a high glycolytic phenotype, prostate cancer is effectively transported to the breast via SLC16A1 and SLC16A4.The expression level of SLC16A1 in metastatic prostate cancer cells is significantly higher than that in more restricted prostate cancer cell lines.